Literature DB >> 26108984

Na(+) /H(+) exchanger regulatory factor 1 knockout mice have an attenuated hepatic inflammatory response and are protected from cholestatic liver injury.

Man Li1, Albert Mennone1, Carol J Soroka1, Lee R Hagey2, Xinshou Ouyang1, Edward J Weinman3,4, James L Boyer1.   

Abstract

UNLABELLED: The intercellular adhesion molecule 1 (ICAM-1) is induced in mouse liver after bile duct ligation (BDL) and plays a key role in neutrophil-mediated liver injury in BDL mice. ICAM-1 has been shown to interact with cytoskeletal ezrin-radixin-moesin (ERM) proteins that also interact with the PDZ protein, Na(+) /H(+) exchanger regulatory factor 1 (NHERF-1/EBP50). In NHERF-1(-/-) mice, ERM proteins are significantly reduced in brush-border membranes from kidney and small intestine. ERM knockdown reduces ICAM-1 expression in response to tumor necrosis factor alpha. Here we show that NHERF-1 assembles ERM proteins, ICAM-1 and F-actin into a macromolecule complex that is increased in mouse liver after BDL. Compared to wild-type (WT) mice, both sham-operated and BDL NHERF-1(-/-) mice have lower levels of activated ERM and ICAM-1 protein in the liver accompanied by significantly reduced hepatic neutrophil accumulation, serum alanine aminotransferase, and attenuated liver injury after BDL. However, total bile acid concentrations in serum and liver of sham and BDL NHERF-1(-/-) mice were not significantly different from WT controls, although hepatic tetrahydroxylated bile acids and Cyp3a11 messenger RNA levels were higher in NHERF-1(-/-) BDL mice.
CONCLUSION: NHERF-1 participates in the inflammatory response that is associated with BDL-induced liver injury. Deletion of NHERF-1 in mice leads to disruption of the formation of ICAM-1/ERM/NHERF-1 complex and reduction of hepatic ERM proteins and ICAM-1, molecules that are up-regulated and are essential for neutrophil-mediated liver injury in cholestasis. Further study of the role of NHERF-1 in the inflammatory response in cholestasis and other forms of liver injury should lead to discovery of new therapeutic targets in hepatic inflammatory diseases.
© 2015 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26108984      PMCID: PMC4589453          DOI: 10.1002/hep.27956

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  43 in total

1.  Preparation and specific applications of isolated hepatocyte couplets.

Authors:  J L Boyer; J M Phillips; J Graf
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

Review 2.  Bile acid regulation of hepatic physiology: IV. Bile acids and death receptors.

Authors:  Hajime Higuchi; Gregory J Gores
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-05       Impact factor: 4.052

3.  A kinase-regulated PDZ-domain interaction controls endocytic sorting of the beta2-adrenergic receptor.

Authors:  T T Cao; H W Deacon; D Reczek; A Bretscher; M von Zastrow
Journal:  Nature       Date:  1999-09-16       Impact factor: 49.962

4.  Intercellular adhesion molecule-1 (ICAM-1) expression in the liver of patients with extrahepatic cholestasis.

Authors:  M V Gulubova
Journal:  Acta Histochem       Date:  1998-02       Impact factor: 2.479

5.  Effect of S-adenosylmethionine versus tauroursodeoxycholic acid on bile acid-induced apoptosis and cytolysis in rat hepatocytes.

Authors:  C Benz; S Angermüller; P Klöters-Plachky; P Sauer; W Stremmel; A Stiehl
Journal:  Eur J Clin Invest       Date:  1998-07       Impact factor: 4.686

6.  Functional importance of ICAM-1 in the mechanism of neutrophil-induced liver injury in bile duct-ligated mice.

Authors:  Jaspreet S Gujral; Jie Liu; Anwar Farhood; Jack A Hinson; Hartmut Jaeschke
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-10-16       Impact factor: 4.052

7.  Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas.

Authors:  W A Faubion; M E Guicciardi; H Miyoshi; S F Bronk; P J Roberts; P A Svingen; S H Kaufmann; G J Gores
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

8.  Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation.

Authors:  Marieke H Schoemaker; Willemijn M Gommans; Laura Conde de la Rosa; Manon Homan; Pieter Klok; Christian Trautwein; Harry van Goor; Klaas Poelstra; Hidde J Haisma; Peter L M Jansen; Han Moshage
Journal:  J Hepatol       Date:  2003-08       Impact factor: 25.083

9.  Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways.

Authors:  Marieke H Schoemaker; Laura Conde de la Rosa; Manon Buist-Homan; Titia E Vrenken; Rick Havinga; Klaas Poelstra; Hidde J Haisma; Peter L M Jansen; Han Moshage
Journal:  Hepatology       Date:  2004-06       Impact factor: 17.425

10.  Down-regulation of expression and function of the rat liver Na+/bile acid cotransporter in extrahepatic cholestasis.

Authors:  C Gartung; M Ananthanarayanan; M A Rahman; S Schuele; S Nundy; C J Soroka; A Stolz; F J Suchy; J L Boyer
Journal:  Gastroenterology       Date:  1996-01       Impact factor: 22.682

View more
  10 in total

Review 1.  New roles of the Na+/H+ exchange regulatory factor 1 scaffolding protein: a review.

Authors:  Adrienne M Bushau-Sprinkle; Eleanor D Lederer
Journal:  Am J Physiol Renal Physiol       Date:  2020-01-27

2.  Loss of the Na+/H+ Exchange Regulatory Factor 1 Increases Susceptibility to Cisplatin-Induced Acute Kidney Injury.

Authors:  Adrienne Bushau-Sprinkle; Michelle Barati; Caryl Conklin; Tess Dupre; Kenneth B Gagnon; Syed J Khundmiri; Barbara Clark; Leah Siskind; Mark A Doll; Madhavi Rane; Michael Brier; Susan Coventry; Eleanor D Lederer
Journal:  Am J Pathol       Date:  2019-03-27       Impact factor: 4.307

3.  The Role of Inflammation in the Mechanisms of Bile Acid-Induced Liver Damage.

Authors:  Shi-Ying Cai; James L Boyer
Journal:  Dig Dis       Date:  2017-03-01       Impact factor: 2.404

Review 4.  Mechanisms of bile acid mediated inflammation in the liver.

Authors:  Man Li; Shi-Ying Cai; James L Boyer
Journal:  Mol Aspects Med       Date:  2017-07-01

5.  Functional role and regulation of permeability-glycoprotein (P-gp) in the fetal membrane during drug transportation.

Authors:  Ananthkumar Kammala; Meagan Benson; Esha Ganguly; Lauren Richardson; Ramkumar Menon
Journal:  Am J Reprod Immunol       Date:  2021-12-15       Impact factor: 3.886

6.  Huangqi Decoction Alleviates Alpha-Naphthylisothiocyanate Induced Intrahepatic Cholestasis by Reversing Disordered Bile Acid and Glutathione Homeostasis in Mice.

Authors:  Jia-Sheng Wu; Yi-Fei Li; Yuan-Yuan Li; Yan Dai; Wen-Kai Li; Min Zheng; Zheng-Chun Shi; Rong Shi; Tian-Ming Wang; Bing-Liang Ma; Ping Liu; Yue-Ming Ma
Journal:  Front Pharmacol       Date:  2017-12-21       Impact factor: 5.810

Review 7.  The Biological Relevance of NHERF1 Protein in Gynecological Tumors.

Authors:  Margherita Sonnessa; Sara Sergio; Concetta Saponaro; Michele Maffia; Daniele Vergara; Francesco Alfredo Zito; Andrea Tinelli
Journal:  Front Oncol       Date:  2022-02-11       Impact factor: 6.244

8.  The impact of sterile inflammation in acute liver injury.

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  J Clin Transl Res       Date:  2017-02-12

9.  NHERF1 Loss Upregulates Enzymes of the Pentose Phosphate Pathway in Kidney Cortex.

Authors:  Adrienne Bushau-Sprinkle; Michelle T Barati; Kenneth B Gagnon; Syed Jalal Khundmiri; Kathleen Kitterman; Bradford G Hill; Amanda Sherwood; Michael Merchant; Shesh N Rai; Sudhir Srivastava; Barbara Clark; Leah Siskind; Michael Brier; Jessica Hata; Eleanor Lederer
Journal:  Antioxidants (Basel)       Date:  2020-09-14

10.  Sodium Hydrogen Exchanger Regulatory Factor-1 (NHERF1) Regulates Fetal Membrane Inflammation.

Authors:  Ananth Kumar Kammala; Samantha Sheller-Miller; Enkhtuya Radnaa; Talar Kechichian; Hariharan Subramanian; Ramkumar Menon
Journal:  Int J Mol Sci       Date:  2020-10-20       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.